Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shantanu Banerji

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Therapeutic Advances in Medical Oncology|June 28, 2021
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access programOliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature|June 23, 2012
Sequence analysis of mutations and translocations across breast cancer subtypesShantanu Banerji, Kristian Cibulskis, Claudia Rangel-Escareno, et al.
Nature Genetics|September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerMartin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Therapeutic Advances in Medical Oncology|June 28, 2021
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access programOliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature|June 23, 2012
Sequence analysis of mutations and translocations across breast cancer subtypesShantanu Banerji, Kristian Cibulskis, Claudia Rangel-Escareno, et al.
Nature Genetics|September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerMartin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Pageof 5